Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy H Chau

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|December 5, 2024
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of HealthOluwatobi T Arisa, Erica L Beatson, Annieka Reno, et al.
Cancer Biology & Therapy|October 6, 2005
Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancerCindy H Chau, Matthew G Permenter, Seth M Steinberg, et al.
Oncotarget|April 28, 2016
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systemsShaunna L Beedie, Holly M Rore, Shelby Barnett, et al.
American Journal of Physiology. Cell Physiology|March 25, 2005
Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systemsCindy H Chau, Carlos A Clavijo, Hong-Tao Deng, et al.
Molecular Cancer Therapeutics|February 26, 2021
Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer ModelsKeith T Schmidt, Cindy H Chau, Jonathan D Strope, et al.
Communications Biology|March 26, 2026
Hypoxic regulation of chromatin and gene transcriptionJessica D Kindrick, Olivia Lombardi, Silvia Halim, et al.
Biochemical and Biophysical Research Communications|December 14, 2020
On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugsChristopher Heim, Samuel Maiwald, Christian Steinebach, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2020
Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugsShaunna L Beedie, Phoebe A Huang, Emily M Harris, et al.
Oncogene|December 17, 2002
Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferationCindy H Chau, Kai-Yun Chen, Hong-Tao Deng, et al.
Endocrine-Related Cancer|December 10, 2021
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trialCindy H Chau, Cathee Till, Douglas K Price, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|December 5, 2024
Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of HealthOluwatobi T Arisa, Erica L Beatson, Annieka Reno, et al.
Cancer Biology & Therapy|October 6, 2005
Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancerCindy H Chau, Matthew G Permenter, Seth M Steinberg, et al.
Oncotarget|April 28, 2016
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systemsShaunna L Beedie, Holly M Rore, Shelby Barnett, et al.
American Journal of Physiology. Cell Physiology|March 25, 2005
Etk/Bmx mediates expression of stress-induced adaptive genes VEGF, PAI-1, and iNOS via multiple signaling cascades in different cell systemsCindy H Chau, Carlos A Clavijo, Hong-Tao Deng, et al.
Molecular Cancer Therapeutics|February 26, 2021
Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer ModelsKeith T Schmidt, Cindy H Chau, Jonathan D Strope, et al.
Communications Biology|March 26, 2026
Hypoxic regulation of chromatin and gene transcriptionJessica D Kindrick, Olivia Lombardi, Silvia Halim, et al.
Biochemical and Biophysical Research Communications|December 14, 2020
On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugsChristopher Heim, Samuel Maiwald, Christian Steinebach, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 18, 2020
Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugsShaunna L Beedie, Phoebe A Huang, Emily M Harris, et al.
Oncogene|December 17, 2002
Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferationCindy H Chau, Kai-Yun Chen, Hong-Tao Deng, et al.
Endocrine-Related Cancer|December 10, 2021
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trialCindy H Chau, Cathee Till, Douglas K Price, et al.
Pageof 8